Literature DB >> 3181261

Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group.

A T van Oosterom1, M S Aapro, F Carnino, M E van der Burg, S Pecorelli, N Rotmensz, O Dalesio, J B Vermorken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181261     DOI: 10.1016/0277-5379(88)90233-7

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


× No keyword cloud information.
  1 in total

1.  Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer.

Authors:  M D Green; J L Speyer; J C Wernz; N Colombo; U Beller; F M Muggia; E M Beckman
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.